Applying Next-Generation Sequencing Platforms for Pharmacogenomic Testing in Clinical Practice

被引：30

作者：

Tafazoli, Alireza ^{[1
,2
]}

Guchelaar, Henk-Jan ^{[3
,4
]}

Miltyk, Wojciech ^{[1
]}

Kretowski, Adam J. ^{[2
,5
]}

Swen, Jesse J. ^{[3
,4
]}

机构：

[1] Med Univ Bialystok, Fac Pharm, Dept Anal & Bioanal Med, Div Lab Med, Bialystok, Poland

[2] Med Univ Bialystok, Clin Res Ctr, Bialystok, Poland

[3] Leiden Univ, Dept Clin Pharm & Toxicol, Med Ctr, Leiden, Netherlands

[4] Leiden Network Personalized Therapeut, Leiden, Netherlands

[5] Med Univ Bialystok, Dept Endocrinol Diabetol & Internal Med, Bialystok, Poland

来源：

FRONTIERS IN PHARMACOLOGY | 2021年 / 12卷

基金：

欧盟地平线“2020”;

关键词：

pharmacogenomics; clinical implementation; next generation sequencing; clinical practice; PGx testing; IMPLEMENTATION CONSORTIUM; INCIDENTAL FINDINGS; CYP2D6; DRUG; GENOTYPE; CHALLENGES; EXOME; RECOMMENDATIONS; INFORMATION; MUTATIONS;

D O I：

10.3389/fphar.2021.693453

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Pharmacogenomics (PGx) studies the use of genetic data to optimize drug therapy. Numerous clinical centers have commenced implementing pharmacogenetic tests in clinical routines. Next-generation sequencing (NGS) technologies are emerging as a more comprehensive and time- and cost-effective approach in PGx. This review presents the main considerations for applying NGS in guiding drug treatment in clinical practice. It discusses both the advantages and the challenges of implementing NGS-based tests in PGx. Moreover, the limitations of each NGS platform are revealed, and the solutions for setting up and management of these technologies in clinical practice are addressed.

引用

页数：15

共 50 条

[1] Comparison of Next-Generation Sequencing and Mutation-Specific Platforms in Clinical Practice
Hinrichs, John W. J.
Van Blokland, W. T. Marja
Moons, Michiel J.
Radersma, Remco D.
Radersma-Van Loon, Joyce H.
de Voijs, Carmen M. A.
Rappel, Sophie B.
Koudijs, Marco J.
Besselink, Nicolle J. M.
Willems, Stefan M.
de Weger, Roel A.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2015, 143 (04) : 573 - 578
[2] Next-Generation Sequencing Platforms
Mardis, Elaine R.
ANNUAL REVIEW OF ANALYTICAL CHEMISTRY, VOL 6, 2013, 6 : 287 - 303
[3] Next-generation sequencing and clinical histocompatibility testing
Cornaby, Caleb
Schmitz, John L.
Weimer, Eric T.
HUMAN IMMUNOLOGY, 2021, 82 (11) : 829 - 837
[4] Implementing Next-Generation Sequencing in Clinical Practice
Watkins, Nicholas A.
Charames, George S.
JOURNAL OF APPLIED LABORATORY MEDICINE, 2018, 3 (02): : 338 - 341
[5] Evaluation of Sequence Capture and Two Next-Generation Sequencing Platforms for Clinical Testing Applications
Hoppman-Chaney, N.
Peterson, L. M.
Klee, E.
Middha, S.
Courteau, L. K.
Ferber, M. J.
JOURNAL OF MOLECULAR DIAGNOSTICS, 2009, 11 (06): : 671 - 672
[6] Pharmacogenomic Testing and Somatic Next-Generation Sequencing of Patients with Advanced Solid Tumors
Bouma, M.
Wake, D.
Moorthy, G.
Serieka, A.
Ochs, L.
Dunnenberger, H.
Sabatini, L.
Mangold, K.
Alikhan, M.
Parilla, M.
Helseth, D.
Miller, N.
Yang, M.
Brueck, J.
Khandekar, J.
Brockstein, B.
Kaul, K.
JOURNAL OF MOLECULAR DIAGNOSTICS, 2023, 25 (11): : S90 - S90
[7] In Silico Proficiency Testing for Clinical Next-Generation Sequencing
Duncavage, Eric J.
Abel, Haley J.
Pfeifer, John D.
JOURNAL OF MOLECULAR DIAGNOSTICS, 2017, 19 (01): : 35 - 42
[8] Clinical application of next-generation sequencing to the practice of neurology
Rexach, Jessica
Lee, Hane
Martinez-Agosto, Julian A.
Nemeth, Andrea H.
Fogel, Brent L.
LANCET NEUROLOGY, 2019, 18 (05): : 492 - 503
[9] Quality Assurance Practice in Clinical Next-Generation Sequencing
Durso, M.
Mantha, G.
Wald, A.
Roy, S.
Ng, Y.
Nikiforova, M. N.
JOURNAL OF MOLECULAR DIAGNOSTICS, 2013, 15 (06): : 903 - 904
[10] The Next, Next-Generation of Sequencing, Promising to Boost Research and Clinical Practice
Kumar, Kishore R.
Cowley, Mark J.
Davis, Ryan L.
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2024, 50 (07): : 1039 - 1046

← 1 2 3 4 5 →